A Case of Lymphangioma Treated by OK-432 (Picibanil(R)) Sclerotherapy / 대한피부과학회지
Korean Journal of Dermatology
;
: 1398-1401, 2008.
Article
in Korean
| WPRIM
| ID: wpr-216600
ABSTRACT
Lymphangioma is an uncommon, benign hyperproliferation of the lymphatic vessels, and this consists of dilated lymphatic channels lined by a normal, single layer of endothelial cells. Various methods have been tried for the treatment of lymphangioma, including cryotherapy, electrocauterization, surgical excision, laser therapy, radiotherapy and itralesional injection of sclerosing agents. Yet these methods have shown low success rates and various side effects. It has recently been reported that intralesional injection of OK-432 is a safe and effective alternative therapy for lymphangioma, and especially for macrocystic lesion. In this report, we describe a patient with lymphangioma on the upper labial mucosa and this patient was successfully treated with intralesional injection of OK-432 without any serious complications. To the best of our knowledge, this is the first such case reported on in the Korean dermatological literature.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Picibanil
/
Sclerosing Solutions
/
Injections, Intralesional
/
Sclerotherapy
/
Cryotherapy
/
Endothelial Cells
/
Lymphatic Vessels
/
Laser Therapy
/
Lymphangioma
/
Mucous Membrane
Limits:
Humans
Language:
Korean
Journal:
Korean Journal of Dermatology
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS